Skip to main content

Advertisement

Log in

Body image, sexual function and depression in Korean patients with breast cancer: modification by 5-HTT polymorphism

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Background

Nearly 50% of women with breast cancer show depressive symptoms after diagnosis and treatment. The purpose of this study was to clarify how psychosocial factors (body image, sexuality, and social relationships) and genetic factors (functional polymorphism of the serotonin transporter-linked promoter region) influence depression.

Methods

The participants were categorized by DSM-IV diagnoses; scored according to their depressive symptoms, body image and social and sexual function (BIRS), self-esteem, and quality of life; and genotyped by functional polymorphism of the serotonin transporter promoter.

Results

Patients with depressive symptoms showed low self-esteem, poor body image, relationship problems, and low quality of life. Genotype frequencies did not differ between two groups categorized by the presence or absence of depressive symptoms. However, the patients with the short allele of the 5-HTTLPR had significantly higher HAM-D scores (F = 7.59, p = 0.047).

Conclusion

The results suggest that psychosocial factors related to breast cancer treatment such as body image, self-esteem, and interpersonal relationship influence the development of depressive symptoms. The 5-HTTLPR may be associated with the severity of depressive symptoms rather than susceptibility to the development of depressive symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2):74–108

    Article  PubMed  Google Scholar 

  2. Shin HR, Jung KW, Won YJ, Park JG (2004) 139 KCCR-affiliated Hospitals. 2002 annual report of the Korea Central Cancer Registry: based on registered data from 139 hospitals. Cancer Res Treat 36:103–114

    Article  PubMed  Google Scholar 

  3. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A et al (2005) Cancer statistics, 2005. CA Cancer J Clin 55(1):10–30

    Article  PubMed  Google Scholar 

  4. Ganz PA (2003) Why and how to study the fate of cancer survivors: observations from the clinic and the research laboratory. Eur J Cancer 39(15):2136–2141

    Article  PubMed  CAS  Google Scholar 

  5. Massie MJ (2004) Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 32:57–71

    Article  PubMed  Google Scholar 

  6. Schou I, Ekeberg O, Ruland CM, Sandvik L, Karesen R (2004) Pessimism as a predictor of emotional morbidity one year following breast cancer surgery. Psychooncology 13(5):309–320

    Article  PubMed  CAS  Google Scholar 

  7. Ayres A, Hoon PW, Franzoni JB, Matheny KB, Cotanch PH, Takayanagi S (1994) Influence of mood and adjustment to cancer on compliance with chemotherapy among breast cancer patients. J Psychosom Res 38(5):393–402

    Article  PubMed  CAS  Google Scholar 

  8. Ell K, Sanchez K, Vourlekis B, Lee PJ, Dwight-Johnson M, Lagomasino I et al (2005) Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecologic cancer. J Clin Oncol 23(13):3052–3060

    Article  PubMed  Google Scholar 

  9. Hjerl K, Andersen EW, Keiding N, Mouridsen HT, Mortensen PB, Jorgensen T (2003) Depression as a prognostic factor for breast cancer mortality. Psychosomatics 44(1):24–30

    Article  PubMed  Google Scholar 

  10. Bardwell WA, Natarajan L, Dimsdale JE, Rock CL, Mortimer JE, Hollenbach K et al (2006) Objective cancer-related variables are not associated with depressive symptoms in women treated for early-stage breast cancer. J Clin Oncol 24(16):2420–2427

    Article  PubMed  Google Scholar 

  11. Vahdaninia M, Omidvari S, Montazeri A (2010) What do predict anxiety and depression in breast cancer patients? A follow-up study. Soc Psychiatry Psychiat Epidemiol 45(3):355–361

    Article  Google Scholar 

  12. Montazeri A (2008) Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res 27:32

    Article  PubMed  Google Scholar 

  13. Malhi GS, Moore J, McGuffin P (2000) The genetics of major depressive disorder. Curr Psychiatry Rep 2(2):165–169

    Article  PubMed  CAS  Google Scholar 

  14. Morris PL, Robinson RG, Raphael B, Samuels J, Molloy P (1992) The relationship between risk factors for affective disorder and poststroke depression in hospitalised stroke patients. Aust N Z J Psychiatry 26(2):208–217

    Article  PubMed  CAS  Google Scholar 

  15. Owens MJ, Nemeroff CB (1994) Role of serotonin in the pathophysiology of depression: Focus on the serotonin transporter. Clin Chem 40(2):288–295

    PubMed  CAS  Google Scholar 

  16. Pirker W, Asenbaum S, Kasper S, Walter H, Angelberger P, Koch G et al (1995) Beta-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo. J Neural Transm Gen Sect 100(3):247–256

    Article  PubMed  CAS  Google Scholar 

  17. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274(5292):1527–1531

    Article  PubMed  CAS  Google Scholar 

  18. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H et al (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301(5631):386–389

    Article  PubMed  CAS  Google Scholar 

  19. Anguelova M, Benkelfat C, Turecki G (2003) A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: Ii. Suicidal behavior. Mol Psychiatry 8(7):646–653

    Article  PubMed  CAS  Google Scholar 

  20. Serretti A, Calati R, Mandelli L, De Ronchi D (2006) Serotonin transporter gene variants and behavior: a comprehensive review. Curr Drug Targets 7(12):1659–1669

    Article  PubMed  CAS  Google Scholar 

  21. Greenberg BD, Tolliver TJ, Huang SJ, Li Q, Bengel D, Murphy DL (1999) Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 88(1):83–87

    Article  PubMed  CAS  Google Scholar 

  22. Grassi L, Rossi E, Cobianchi M, Aguiari L, Capozzo M, Martinis E et al (2010) Depression and serotonin transporter (5-HTTLPR) polymorphism in breast cancer patients. J Affect Disord 124(3):346–350

    Article  PubMed  CAS  Google Scholar 

  23. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370

    Article  PubMed  CAS  Google Scholar 

  24. Lloyd-Williams M, Friedman T, Rudd N (2001) An analysis of the validity of the Hospital Anxiety and Depression Scale as a screening tool in patients with advanced metastatic cancer. J Pain Symptom Manage 22(6):990–996

    Article  PubMed  CAS  Google Scholar 

  25. Aaronson NK, Ahmedzai S, Bergman B, Li Q, Bengel D, Murphy DL (1983) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376

    Article  Google Scholar 

  26. Sprangers MA, Groenvold M, Arraras JI, Franklin J, te Velde A, Muller M et al (1996) The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol 14(10):2756–2768

    PubMed  CAS  Google Scholar 

  27. Yun YH, Park YS, Lee ES, Bang SM, Heo DS, Park SY et al (2004) Validation of the Korean version of the EORTC-QLQ-C30. Qual Life Res 13(4):863–868

    Article  PubMed  CAS  Google Scholar 

  28. Yun YH, Bae SH, Kang IO, Shin KH, Lee R, Kwon SI et al (2004) Cross-cultural application of the korean version of the European Organization for Research and Treatment of Cancer (EORTC) Breast-Cancer-Specific Quality of Life Qquestionnaire (EORTC QLQ-C30). Support Care Cancer 12(6):441–445

    Article  PubMed  Google Scholar 

  29. Collier DA, Stöber G, Li T, Heils A, Catalano M, Di Bella D et al (1996) A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry 1(6):453–460

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by a faculty research grant of from the Yonsei University College of Medicine (No. 6-2008-0139).

Financial disclosure/Conflict of interest

We have no financial disclosures and conflicts of interest to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kee Namkoong.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, K.R., Chung, H.C., Lee, E. et al. Body image, sexual function and depression in Korean patients with breast cancer: modification by 5-HTT polymorphism. Support Care Cancer 20, 2177–2182 (2012). https://doi.org/10.1007/s00520-011-1329-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-011-1329-z

Keywords

Navigation